61 results
8-K
BTAI
BioXcel Therapeutics Inc
25 Mar 24
Entry into a Material Definitive Agreement
4:05pm
(the “Prospectus Supplement”). The closing of the Offering is expected to occur on or about March 27, 2024, subject to the satisfaction of customary … as a result of various important factors, including, without limitation, the risks and uncertainties associated with market conditions, the satisfaction
8-K
EX-4.2
BTAI
BioXcel Therapeutics Inc
25 Mar 24
Entry into a Material Definitive Agreement
4:05pm
in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a “Buy
8-K
EX-10.1
BTAI
BioXcel Therapeutics Inc
25 Mar 24
Entry into a Material Definitive Agreement
4:05pm
and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set
8-K
EX-4.1
BTAI
BioXcel Therapeutics Inc
25 Mar 24
Entry into a Material Definitive Agreement
4:05pm
market prices) shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving
8-K
EX-10.1
750q7 ryhaq
12 Feb 24
Entry into a Material Definitive Agreement
12:45pm
8-K
EX-10.1
d1sjdh5hebacb
8 Feb 24
Other Events
4:53pm
8-K
EX-10.1
yk9gvgns6y 3fu4p
19 Aug 22
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.2
myqulyfke1ie 0bmv
19 Aug 22
Departure of Directors or Certain Officers
4:15pm